These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29866748)

  • 1. Response by Ducroux et al to Letter Regarding Article, "Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke".
    Ducroux C; Desilles JP; Ho-Tin-Noe B
    Stroke; 2018 Jul; 49(7):e266. PubMed ID: 29866748
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by van de Graaf et al Regarding Article, "Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke".
    van de Graaf RA; van Beusekom HMM; Roozenbeek B
    Stroke; 2018 Jul; 49(7):e265. PubMed ID: 29866759
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke.
    Ducroux C; Di Meglio L; Loyau S; Delbosc S; Boisseau W; Deschildre C; Ben Maacha M; Blanc R; Redjem H; Ciccio G; Smajda S; Fahed R; Michel JB; Piotin M; Salomon L; Mazighi M; Ho-Tin-Noe B; Desilles JP
    Stroke; 2018 Mar; 49(3):754-757. PubMed ID: 29438080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of COVID-19 on thrombus composition and response to thrombolysis: Insights from a monocentric cohort population of COVID-19 patients with acute ischemic stroke.
    Desilles JP; Solo Nomenjanahary M; Consoli A; Ollivier V; Faille D; Bourrienne MC; Hamdani M; Dupont S; Di Meglio L; Escalard S; Maier B; Blanc R; Piotin M; Lapergue B; Ajzenberg N; Vasse M; Mazighi M; Ho-Tin-Noé B; ; Désilles JP; Mazighi M; Piotin M; Blanc R; Redjem H; Smajda S; Seners P; Escalard S; Delvoye F; Maier B; Hebert S; Ben Maacha M; Hamdani M; Sabben C; Obadia M; Deschildre C; Lapergue B; Consoli A; Rodesch G; Maria F; Coskun O; Lopez D; Bourcier R; Detraz L; Desal H; Roy M; Clavier D; Marnat G; Gariel F; Lucas L; Sibon I; Eugene F; Vannier S; Ferre JC; LeBras A; Raoult H; Paya C; Gauvrit JY; Richard S; Gory B; Barbier C; Vivien D; Touze E; Gauberti M; Blaizot G; Ifergan H; Herbreteau D; Bibi R; Janot K; Charron V; Boulouis G
    J Thromb Haemost; 2022 Apr; 20(4):919-928. PubMed ID: 35032088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance.
    Peña-Martínez C; Durán-Laforet V; García-Culebras A; Ostos F; Hernández-Jiménez M; Bravo-Ferrer I; Pérez-Ruiz A; Ballenilla F; Díaz-Guzmán J; Pradillo JM; Lizasoain I; Moro MA
    Stroke; 2019 Nov; 50(11):3228-3237. PubMed ID: 31526124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil extracellular traps in ischemic stroke thrombi.
    Laridan E; Denorme F; Desender L; François O; Andersson T; Deckmyn H; Vanhoorelbeke K; De Meyer SF
    Ann Neurol; 2017 Aug; 82(2):223-232. PubMed ID: 28696508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.
    Liu S; Feng X; Jin R; Li G
    Expert Opin Drug Deliv; 2018 Feb; 15(2):173-184. PubMed ID: 28944694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke.
    Doepp F; Sanad W; Schreiber SJ; Baumann G; Borges AC
    Cardiovasc Ultrasound; 2005 May; 3():14. PubMed ID: 15918893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P
    Chest; 2008 Jun; 133(6 Suppl):630S-669S. PubMed ID: 18574275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke.
    Hu J; Huang S; Zhu L; Huang W; Zhao Y; Jin K; ZhuGe Q
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):32988-32997. PubMed ID: 30192506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischaemic stroke and the recanalization drug tissue plasminogen activator interfere with antibacterial phagocyte function.
    Vogelgesang A; Lange C; Blümke L; Laage G; Rümpel S; Langner S; Bröker BM; Dressel A; Ruhnau J
    J Neuroinflammation; 2017 Jul; 14(1):140. PubMed ID: 28732504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.
    Yepes M; Roussel BD; Ali C; Vivien D
    Trends Neurosci; 2009 Jan; 32(1):48-55. PubMed ID: 18963068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
    Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response by Spaander et al to Letter Regarding Article, "Sex Differences and Functional Outcome After Intravenous Thrombolysis".
    Spaander FH; Nederkoorn PJ;
    Stroke; 2017 Jul; 48(7):e175. PubMed ID: 28546327
    [No Abstract]   [Full Text] [Related]  

  • 16. Response by Spaander et al to Letter Regarding Article, "Sex Differences and Functional Outcome After Intravenous Thrombolysis".
    Spaander FH; Nederkoorn PJ;
    Stroke; 2017 Nov; 48(11):e330. PubMed ID: 28939670
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of alcohol consumption on the outcome of ischemic stroke and thrombolysis: role of the hepatic clearance of tissue-type plasminogen activator.
    Lemarchand E; Gauberti M; Martinez de Lizarrondo S; Villain H; Repessé Y; Montagne A; Vivien D; Ali C; Rubio M
    Stroke; 2015 Jun; 46(6):1641-50. PubMed ID: 25922513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeable Thrombi Are Associated With Higher Intravenous Recombinant Tissue-Type Plasminogen Activator Treatment Success in Patients With Acute Ischemic Stroke.
    Santos EM; Dankbaar JW; Treurniet KM; Horsch AD; Roos YB; Kappelle LJ; Niessen WJ; Majoie CB; Velthuis B; Marquering HA;
    Stroke; 2016 Aug; 47(8):2058-65. PubMed ID: 27338928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of acute ischemic stroke. What is the role of tPA and antithrombotic agents?
    Meschia JF
    Postgrad Med; 2000 May; 107(6):85-6, 89-93. PubMed ID: 10865869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.